![N-[7-(beta-D-galactopyranosyloxy)-4-methyl-2-oxo-2H-chromen-6-yl]-2-methylpentadecanamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F285874-n-7-beta-d-galactopyranosyloxy-4-methyl-2-oxo-2h-chromen-6-yl-2-methylpentadecanamide.webp&w=3840&q=75)
CAS 94452-17-2: N-[7-(beta-D-galactopyranosyloxy)-4-methyl-2-oxo-2H-chromen-6-yl]-2-methylpentadecanamide
Formula:C32H49NO9
InChI:InChI=1/C32H49NO9/c1-4-5-6-7-8-9-10-11-12-13-14-15-20(2)31(39)33-23-17-22-21(3)16-27(35)40-24(22)18-25(23)41-32-30(38)29(37)28(36)26(19-34)42-32/h16-18,20,26,28-30,32,34,36-38H,4-15,19H2,1-3H3,(H,33,39)/t20?,26-,28+,29+,30-,32-/m1/s1
Sort by
Found 3 products.
6-Hexadecanoylamino-4-methylumbelliferyl b-D-Galactopyranoside
CAS:Formula:C32H49NO9Color and Shape:NeatMolecular weight:591.736-Hexadecanoylamino-4-methylumbelliferyl b-D-Galactopyranoside
CAS:Formula:C32H49NO9Molecular weight:591.736-Hexadecanoylamino-4-methylumbelliferyl b-D-galactopyranoside - Moscerdam™ biochemical purity
CAS:Hexadecanoylamino-4-methylumbelliferyl b-D-galactopyranoside is a substrate used for the diagnosis of Krabbe disease. Krabbe disease (globoid cell leukodystrophy/ galactosylceramide lipidosis), is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. It is inherited in an autosomal recessive pattern and involves dysfunctional metabolism of sphingolipids (MG44866 b-D-Galactosylsphingosine - Synthetic)Formula:C32H49NO9Purity:Min. 95 Area-%Color and Shape:White PowderMolecular weight:591.73 g/mol
